Program overview
Context
Indication: Advanced, Persistent, or Recurrent Endometrial Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: GOG Foundation
Everolimus is flagged as results not found signal because public records show public results not found after completion, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Advanced, Persistent, or Recurrent Endometrial Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: GOG Foundation
Registry: 0/5
Timeline: 1/5
Recruitment burden: 2/5
Results availability: 3/5
Program risk: 3/5
https://clinicaltrials.gov/study/NCT02228681 | https://clinicaltrials.gov/study/NCT00618345
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02228681 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |
| NCT00618345 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | strict_eligibility_signal |